Arcadia Biosciences, Inc. (RKDA) Stock Analysis & Investment Frameworks
Arcadia Biosciences, Inc. (RKDA) stock analysis on Invetso. Review Arcadia Biosciences, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Arcadia Biosciences, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Basic Materials
- Industry: Agricultural Inputs
- Country: US
Arcadia Biosciences, Inc. Key Financial Metrics
- Market Cap: $673702.00
- Revenue: $4.86M
- ROE: -339.85%
- ROIC: -95.57%
- Dividend Yield: N/A
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
Arcadia Biosciences, Inc. Investment Frameworks
Invetso analyzes Arcadia Biosciences, Inc. (RKDA) across the following frameworks:
- Arcadia Biosciences, Inc. 10Y Growth Potential
- Arcadia Biosciences, Inc. Scenario Analysis
- Arcadia Biosciences, Inc. Risks & Opportunities
- Arcadia Biosciences, Inc. Economic Moat
- Arcadia Biosciences, Inc. Business Model
- Arcadia Biosciences, Inc. Management
- Arcadia Biosciences, Inc. SWOT Analysis
- Arcadia Biosciences, Inc. Porter's 5 Forces
- Arcadia Biosciences, Inc. PESTLE Analysis
- Arcadia Biosciences, Inc. ESG Analysis